IL109254A - History of the tetrahydropyran and tetrahydropuran site preparation and pharmaceutical preparations containing them - Google Patents

History of the tetrahydropyran and tetrahydropuran site preparation and pharmaceutical preparations containing them

Info

Publication number
IL109254A
IL109254A IL10925494A IL10925494A IL109254A IL 109254 A IL109254 A IL 109254A IL 10925494 A IL10925494 A IL 10925494A IL 10925494 A IL10925494 A IL 10925494A IL 109254 A IL109254 A IL 109254A
Authority
IL
Israel
Prior art keywords
methyl
oxo
hydroxy
tetrahydroquinolin
formula
Prior art date
Application number
IL10925494A
Other languages
English (en)
Hebrew (he)
Other versions
IL109254A0 (en
Original Assignee
Zeneca Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zeneca Ltd filed Critical Zeneca Ltd
Publication of IL109254A0 publication Critical patent/IL109254A0/xx
Publication of IL109254A publication Critical patent/IL109254A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Dermatology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
IL10925494A 1993-04-29 1994-04-07 History of the tetrahydropyran and tetrahydropuran site preparation and pharmaceutical preparations containing them IL109254A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP93401120 1993-04-29
EP93401991 1993-08-02
EP94400190 1994-01-28

Publications (2)

Publication Number Publication Date
IL109254A0 IL109254A0 (en) 1994-07-31
IL109254A true IL109254A (en) 1999-03-12

Family

ID=27235558

Family Applications (1)

Application Number Title Priority Date Filing Date
IL10925494A IL109254A (en) 1993-04-29 1994-04-07 History of the tetrahydropyran and tetrahydropuran site preparation and pharmaceutical preparations containing them

Country Status (24)

Country Link
US (2) US5478842A (fi)
EP (1) EP0623614B1 (fi)
JP (1) JP3553127B2 (fi)
KR (1) KR100358464B1 (fi)
CN (1) CN1052002C (fi)
AP (1) AP9400632A0 (fi)
AT (1) ATE163417T1 (fi)
AU (1) AU681886B2 (fi)
CA (1) CA2121199C (fi)
CZ (1) CZ280695A3 (fi)
DE (1) DE69408593T2 (fi)
DK (1) DK0623614T3 (fi)
ES (1) ES2112483T3 (fi)
FI (2) FI109123B (fi)
GB (1) GB9408001D0 (fi)
HK (1) HK1004777A1 (fi)
HU (1) HU9502968D0 (fi)
IL (1) IL109254A (fi)
NO (1) NO309191B1 (fi)
NZ (1) NZ266139A (fi)
PL (1) PL311300A1 (fi)
SK (1) SK134995A3 (fi)
TW (1) TW252978B (fi)
WO (1) WO1994025453A1 (fi)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP3990972B2 (ja) * 2001-11-20 2007-10-17 有限会社 キック 血管再狭窄防止薬及び該防止薬がコーティングされた血管内埋め込み器具
SE0104274D0 (sv) * 2001-12-17 2001-12-17 Astrazeneca Ab Novel process
DE102004002557A1 (de) * 2004-01-17 2005-08-04 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verwendung von substituierten Pyrimido(5,4-d)pyrimidinen zur Behandlung von Atemwegserkrankungen
US8158362B2 (en) 2005-03-30 2012-04-17 Decode Genetics Ehf. Methods of diagnosing susceptibility to myocardial infarction and screening for an LTA4H haplotype
EP1978966A4 (en) 2006-01-23 2010-11-10 Amira Pharmaceuticals Inc TRICYCLIC INHIBITORS OF 5-LIPOXYGENASE
WO2008067566A1 (en) 2006-11-30 2008-06-05 Amira Pharmaceuticals, Inc. Compositions and treatments comprising 5-lipoxygenase-activating protein inhibitors and nitric oxide modulators
US10793515B2 (en) * 2008-03-19 2020-10-06 Aurimmed Pharma, Inc. Compounds advantageous in the treatment of central nervous system diseases and disorders
EP3791880A1 (en) 2009-04-29 2021-03-17 Amarin Pharmaceuticals Ireland Limited Pharmaceutical compositions comprising epa
CN106456624B (zh) 2014-02-04 2020-05-22 生物制药合伙公司 Flap抑制剂的降低中枢神经***内的神经炎症介导的损伤的应用
ME03663B (me) 2015-05-04 2020-07-20 Astrazeneca Ab Derivati rirazola korisni kao inhibitori proteina koji aktivira 5-lipoksigenazu (flap)
SG11201903414SA (en) 2016-10-28 2019-05-30 Astrazeneca Ab Crystalline form of (1r,2r)-2-[4-(3-methy1-1h-pyrazol-5-yl)benzoyl]-n-(4-oxo-4,5,6,7-tetrahydropyrazolo[1,5-a]pyrazin-3-yl)cyclohexanecarboxamide

Family Cites Families (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4567184A (en) * 1982-12-01 1986-01-28 Usv Pharmaceutical Corporation Certain aryl or hetero-aryl derivatives of 1-hydroxy-pentane or 1-hydroxy-hexane which are useful for treating inflammation and allergies
US4794188A (en) * 1982-12-01 1988-12-27 Usv Pharmaceutical Corporation Certain unsymmetrical quinolinyl ethers having anti-inflammatory and anti-allergic activity
US4625034A (en) * 1985-02-04 1986-11-25 Usv Pharmaceutical Corp. 1,2-Dihydro; 1,2,3,4-tetrahydro; 5,8 dihydro; and 5,6,7,8-tetrahydroquinoline derivatives
US4728668A (en) * 1985-04-16 1988-03-01 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4631287A (en) * 1985-04-16 1986-12-23 Usv Pharmaceutical Corp. Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4839369A (en) * 1985-04-16 1989-06-13 Rorer Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4725619A (en) * 1985-04-16 1988-02-16 Usv Pharmaceutical Corporation Aryl and heteroaryl ethers as agents for the treatment of hypersensitive ailments
US4868193A (en) * 1986-09-24 1989-09-19 Rorer Pharmaceutical Corporation Styryl tetrazoles and anti-allergic use thereof
US5234950A (en) * 1988-12-23 1993-08-10 Imperial Chemical Industries Plc Tetrahydrofuran derivatives
GB8926981D0 (en) * 1988-12-23 1990-01-17 Ici Plc Heterocyclic derivatives
IE70521B1 (en) * 1989-02-28 1996-12-11 Zeneca Pharma Sa Heterocycles with inhibitory activity of 5-lipoxygenase
US5134148A (en) * 1989-02-28 1992-07-28 Imperial Chemical Industries Plc Heterocycles for use as inhibitors of leukotrienes
US5202326A (en) * 1989-02-28 1993-04-13 Imperial Chemical Industries Plc Heterocyclic ethers
US5236919A (en) * 1989-02-28 1993-08-17 Imperial Chemical Industries Plc Quinoxalinyl derivatives suitable for use in leukotriene mediated disease
IE64358B1 (en) * 1989-07-18 1995-07-26 Ici Plc Diaryl ether heterocycles
GB9018134D0 (en) * 1989-09-29 1990-10-03 Ici Plc Heterocyclic derivatives
US5088927A (en) * 1990-06-18 1992-02-18 Lee Howard G Radio opaque plastics and process of making
IE911853A1 (en) * 1990-06-21 1992-01-01 Ici Plc Heterocyclene derivatives
IE911919A1 (en) * 1990-06-21 1992-01-01 Zeneca Ltd Bicyclic heterocyclic compounds
GB9113137D0 (en) * 1990-07-13 1991-08-07 Ici Plc Thioxo heterocycles
IE913866A1 (en) * 1990-11-28 1992-06-03 Ici Plc Aryl derivatives
US5272173A (en) * 1990-11-28 1993-12-21 Imperial Chemical Industries Plc 5-lipoxygenase inhibitors
EP0501578A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Pyranylphenyl hydroxyalkylnaphthoic acids as inhibitors of leukotriene biosynthesis
EP0501579A1 (en) * 1991-02-28 1992-09-02 Merck Frosst Canada Inc. Naphthalene lactones as inhibitors of leukotriene biosynthesis
US5308852A (en) * 1992-06-29 1994-05-03 Merck Frosst Canada, Inc. Heteroarylnaphthalenes as inhibitors of leukotriene biosynthesis

Also Published As

Publication number Publication date
ATE163417T1 (de) 1998-03-15
HU9502968D0 (en) 1995-12-28
AU681886B2 (en) 1997-09-11
FI955165A (fi) 1995-10-27
NO309191B1 (no) 2000-12-27
FI20020270A (fi) 2002-02-11
AP9400632A0 (en) 1995-10-07
AU6721294A (en) 1994-11-21
KR100358464B1 (ko) 2003-02-05
JP3553127B2 (ja) 2004-08-11
DE69408593D1 (de) 1998-04-02
CN1052002C (zh) 2000-05-03
NO954321D0 (no) 1995-10-27
DK0623614T3 (da) 1998-09-28
CZ280695A3 (en) 1996-01-17
GB9408001D0 (en) 1994-06-15
FI955165A0 (fi) 1995-10-27
CN1121715A (zh) 1996-05-01
NO954321L (no) 1995-10-27
WO1994025453A1 (en) 1994-11-10
ES2112483T3 (es) 1998-04-01
CA2121199C (en) 2001-08-07
DE69408593T2 (de) 1998-07-16
EP0623614B1 (en) 1998-02-25
TW252978B (en) 1995-08-01
CA2121199A1 (en) 1994-10-30
JPH0770114A (ja) 1995-03-14
PL311300A1 (en) 1996-02-05
EP0623614A1 (en) 1994-11-09
US5478842A (en) 1995-12-26
SK134995A3 (en) 1996-07-03
IL109254A0 (en) 1994-07-31
NZ266139A (en) 1997-08-22
FI109123B (fi) 2002-05-31
HK1004777A1 (en) 1998-12-04
US5512594A (en) 1996-04-30

Similar Documents

Publication Publication Date Title
US5217978A (en) Substituted-optionally hydrogenated isoquinoline compounds, pharmaceutical compositions and pharmaceutical method of use
US5240941A (en) Thioxo quinoline compounds, composition and method of use
US5217969A (en) Benzoxazine derivatives as inhibitors of leukotrienes
CA2121199C (en) Ether derivatives
US5420298A (en) Pyrrolidine derivatives
US5254581A (en) Pyran derivatives and their use as inhibitors of 5-lipoxygenase
EP0586229A1 (en) 3-Hydroxy-3-(subst-akyl)-pyrrolidines as 5-lipoxygenase inhibitors
WO1995030668A1 (en) Cyclic ether derivatives and pharmaceutical composition containing them
EP0701560A1 (en) Bicyclic ether derivatives and their use as 5-lipoxygenase inhibitors
WO1995004055A1 (en) Thiazole derivatives as lipoxygenase inhibitors
US5478843A (en) Thiazole derivatives
EP0581464A1 (en) Ester derivatives and pharmaceutical compositions containing them
HU211245A9 (hu) Éterszármazékok Az átmeneti oltalom az 1-9., 11., 13., 14., 16. és 18. igénypontokra vonatkozik.
CA2099819A1 (en) Ester derivatives

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees